NCT05732922: ORCHARD

ORCHARD- Optimising Home Assessment of Rural Patients

Completed NA Last updated 30 March 2025

What this trial tests

NA trial testing A sphygmanometer, a digital thermometer, a pulse oximeter and a peak flow meter will be given to participants to use during their telemedicine consultations with health care providers. in Organ Transplant in 12 participants. Completed in 31 August 2023.

Timeline

1 February 2023

Primary endpoint
31 August 2023

31 August 2023

Quick facts

Lead sponsor	University of Aberdeen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	12
Start date	1 February 2023
Primary completion	31 August 2023
Estimated completion	31 August 2023
Sites	1 location across United Kingdom

Drugs / interventions tested

• A sphygmanometer, a digital thermometer, a pulse oximeter and a peak flow meter will be given to participants to use during their telemedicine consultations with health care providers.

Conditions studied

• Organ Transplant — all drugs for Organ Transplant →
• Cancer — all drugs for Cancer →
• Inborn Errors of Metabolism — all drugs for Inborn Errors of Metabolism →
• Immunosuppression — all drugs for Immunosuppression →

Sponsor

University of Aberdeen

Who can join

Adults 18 to 100, any sex, with Organ Transplant or Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project assesses feasibility of providing medically vulnerable rural patients with Medical-Self-Assessment-Boxes containing equipment to use at home during telephone and video consultations (telemedicine) with GPs and other healthcare professionals. COVID-19 has caused an upsurge in primary care telemedicine which the investigators believe can be sustained and optimized to make things better for medically vulnerable rural patients beyond the pandemic. The investigators will achieve this by equipping the participants to self-measure and report key clinical measurements (e.g. blood pressure, temperature, oxygen levels) during telemedicine consultations. Before conducting a major evaluation of the Medical-Self-Assessment-Box for medically vulnerable rural patients the investigators must establish three things: First, to show the investigators can issue a Medical-Self-Assessment-Box to medically vulnerable rural patients and enable them to use it properly. Second, to determine that patients can use the Medical-Self-Assessment-Box effectively during telemedicine consultations. Third, to show that it is possible to measure how well the Medical-Self-Assessment-Box is working by counting how often the boxes are being used and whether use is appropriate and helpful. The knowledge gained will provide the investigators with the information needed to develop a funding proposal to evaluate Medical-Self-Assessment-Boxes for medically vulnerable rural patients in the whole of the UK.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.